Pharmacogenomics and personalized medicine

来源 :2013年第一届岭南国际DMPK论坛(The 1st Ling-nan International Forum on D | 被引量 : 0次 | 上传用户：littlev19

【摘要】

：

【作者】

：

黄民

【机构】

：

中山大学药学院

【出处】

：

2013年第一届岭南国际DMPK论坛(The 1st Ling-nan International Forum on D

【发表日期】

：

2013年4期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

With recent advances in pharmacogenomics, the involved mechanisms of interiindividual variability have been further explained.A number of studies have demonstrated that the genetic polymorphisms of drug targets, metabolizing enzymes, transport proteins, as well as nuclear receptors play a crucial role in the clinical efficacy and side effects of drugs.

其他文献

Power Analysis by Clinical Trial Simulations to Assess the Effect of CYP2D6 Polymorphism on Chinese

Objective:In vitro information on dextromethorphan (DXM) and the Advanced Dissolution Absorption Metabolism (ADAM) model, incorporated into PBPK simulator Simcyp(@) (v.12) were used to investigate dif

会议

Prediction of First-in-Human Dose of CPRC1 Using Allometric Scaling, IVIVE and PK/PD Modeling Method

Diabetes mellitus is one of the most common chronic disease in the world, CPRC 1 is a novel dipeptidylpeptidase-Ⅳ(DPP-4) inhibitor which was proposed to control hyperglycemia in patients with type 2 d

会议

Pharmacokinetic comparision of berberine in plasma after oral administration of pure berberine in no

In the present study, post inflammation irritable bowel syndrome(PI-IBS) rats were firsty established by intracolonic instillation of acetic acid with restraint stress.Then the pharmacokinetics of ber

会议

Dose finding of antofloxacinhydrochloride for treating bacterialinfectionsin early clinical trial fr

Aim: To find an appropriate dose regimen of antofloxacin, a concentration dependent antibacterial agent,for phase Ⅱ clinical trial through a population pharmacokinetic (PPK) study in healthy volunteer

会议

Study on biotransformation and pharmacokinetic of natural products

Much more attention has been paid to Chinese herbal medicine as for new drug development.Natural products usually metabolize widely in vivo and their metabolic pathways are various and complicated.A p

会议

A dual role of gut microbiota in drug metabolism and disposition

The gut microbiota has been demonstrated to be actively involved in diverse physiological and pathological processes in their hosts through interacting with host cells.This microbial organ also shows

会议

Endogenous cortisol and cortisone metabolism are more effective as a probe in predicting the metabol

The aim of the study was to evaluate if the intestinal metabolism which is greatly affected by the biopharmaceutical character and the CYP3A5 gene variation is important affect factor in predicting th

会议

The Basics of Physiologically-based Pharmacokinetics Modeling and Its Applications in Drug Discovery

The new FDA drug-drug interaction (DDI) guidance permits waiver of clinical DDI trials if the assessment of DDI risks by Physiologically-based Pharmacokinetic (PBPK) modeling is low.In this presentati

会议

Strategy and prospect of biomass spectrometry-based quantitative proteomics in DMPK study

Protein/peptide drugs have attracted more and more attention in recent years.However, the traditional.approach for the pharmacokinetic study of proteins is limited with long term development, high cos

会议

Epigenetics in Drug Metabolism and Pharmacokinetics

Pharmacokinetics involves the study of absorption, distribution, metabolism and excretion (ADME) processes of drugs that is essential for drug discovery and development.These processes are mediated by

会议

Pharmacogenomics and personalized medicine

与本文相关的学术论文